These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9186071)

  • 1. Hyperparathyroidism in the hemodialysis population: a survey of 612 patients.
    Salem MM
    Am J Kidney Dis; 1997 Jun; 29(6):862-5. PubMed ID: 9186071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients.
    Makhlough A; Emadi N; Sedighi O; Khademloo M; Bicmohamadi AR
    Iran J Kidney Dis; 2013 Jan; 7(1):42-6. PubMed ID: 23314141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
    Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
    Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.
    Kalantar-Zadeh K; Miller JE; Kovesdy CP; Mehrotra R; Lukowsky LR; Streja E; Ricks J; Jing J; Nissenson AR; Greenland S; Norris KC
    J Bone Miner Res; 2010 Dec; 25(12):2724-34. PubMed ID: 20614473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of decreasing serum calcium in serum during hemodialysis on PTH levels in children with end stage renal disease].
    Sieniawska M; Ziółkowska H; Pańczyk-Tomaszewska M; Weglarska J
    Pediatr Pol; 1995 Dec; 70(12):1017-22. PubMed ID: 8649940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
    Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
    Shireman TI; Almehmi A; Wetmore JB; Lu J; Pregenzer M; Quarles LD
    Am J Kidney Dis; 2010 Dec; 56(6):1108-16. PubMed ID: 20951487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnant Patient on Hemodialysis Who Showed Remarkable Improvement of Severe Hyperparathyroidism by Strict Serum Phosphorus Control.
    Ito J; Fujii H; Kono K; Goto S; Nishi S
    Intern Med; 2020 Mar; 59(5):689-694. PubMed ID: 31735793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis.
    Goldenberg MM
    Clin Ther; 1999 Mar; 21(3):432-41. PubMed ID: 10321413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism.
    Goodman WG; Belin T; Gales B; Juppner H; Segre GV; Salusky IB
    Kidney Int; 1995 Nov; 48(5):1553-8. PubMed ID: 8544413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium, phosphate, and PTH levels in the hemodialysis population: a multicenter study.
    Gallieni M; Cucciniello E; D'Amaro E; Fatuzzo P; Gaggiotti A; Maringhini S; Rotolo U; Brancaccio D;
    J Nephrol; 2002; 15(2):165-70. PubMed ID: 12018633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral disturbances in patients with chronic kidney disease stage 5 not yet on dialysis.
    Marn Pernat A; Zrimšek M
    Clin Nephrol; 2017 Supplement 1; 88(13):39-43. PubMed ID: 28619127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
    N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 22-oxacalcitriol on secondary hyperparathyroidism in hemodialysis patients.
    Doi S; Yorioka N; Usui K; Shigemoto K; Harada S
    Intern Med; 2003 Oct; 42(10):955-9. PubMed ID: 14606707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.